Dyfyniad APA

Hvisdas, C. (2021). Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm.

Dyfyniad Arddull Chicago

Hvisdas, Christopher. "Revefenacin, a Once-daily, Long-acting Muscarinic Antagonist, for Nebulized Maintenance Therapy in Patients With Chronic Obstructive Pulmonary Disease." Am J Health Syst Pharm 2021.

Dyfyniad MLA

Hvisdas, Christopher. "Revefenacin, a Once-daily, Long-acting Muscarinic Antagonist, for Nebulized Maintenance Therapy in Patients With Chronic Obstructive Pulmonary Disease." Am J Health Syst Pharm 2021.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.